Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled StudyGülen Hatemi, Yusuf Yazıcı, Peter A. Merkel et al.|New England Journal of Medicine|2015Cited by 241
Characteristics of cognitive impairment in adult asymptomatic moyamoya diseaseShihao He, Rong Wang, Ran Duan et al.|BMC Neurology|2020Cited by 39
Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya diseaseZiqi Liu, Rong Wang, Shihao He et al.|BMC Neurology|2020Cited by 30
Brain Functional Network in Chronic Asymptomatic Carotid Artery Stenosis and Occlusion: Changes and CompensationShihao He, Rong Wang, Ziqi Liu et al.|Neural Plasticity|2020Cited by 23
Association between DIAPH1 variant and posterior circulation involvement with Moyamoya diseaseShihao He, Yuanli Zhao, Xiaokuan Hao et al.|Scientific Reports|2023Cited by 7